"Will you commit that when you leave this job, you will not accept compensation from a drug company, a medical device company, a hospital system, or a health insurer for at least four years ...

We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...

Arbuckle, who is overseeing the drug’s launch, said Vertex has been planning for this approval for “a number of years.” The company has amassed 150 staff to sell Journavx, which it priced at $15.50 ...

Earlier in his career, he held positions at pharmaceutical companies including Actavis PLC (now AbbVie, Inc. (ABBV)), the US subsidiary of Swiss company Nycomed Pharma S.A., which has since been ...

Actavis/Allergan shown by putting separate 2014 company sales together ... which finds that novel drugs are increasingly coming from these new entrants. IMS Health analysis found companies ...

In fact, Cuban’s company is planning to begin manufacturing of its own drugs in Texas some time in January 2025, according to Yahoo. The statement was made at a White House roundtable around ...

Healthcare-focused private equity firm Quadria Capital is investing $100 million (about Rs 860 crore) in Hyderabad-based contract drug development and manufacturing company Aragen Life Sciences Ltd.

By increasing the number of manufacturers Cuban's company works with, it can offer more drugs at lower cost, but there's no necessity for manufacturers to work with companies like MCCPDC.

Jan. 29, 2025 — Study finds three new safe and effective drug regimens to fight multidrug-resistant TB. The treatments, which include recently discovered TB drugs, give new options for shorter ...

Here are the next 15 drugs chosen for Medicare negotiations: Ozempic; Rybelsus; Wegovy For treating: Diabetes, obesity Manufacturer: Novo Nordisk ...